🚀 Wall Street Radar: Stocks to Watch Next Week
💼 Volume 45: 💥 S&P 500 Snaps Winning Streak on Israel Attack
Portfolio updates and new positions:
⚡ AI-optimized, human-verified: Our expert team carefully selected Premium market intelligence from Finchat's data. Explore now →
T2118
This week, the market dynamics shifted as the T2118 indicator, closing at 70.12, finally began to curl down in tandem with the major indices. For the last two weeks, we had been observing a clear divergence, with the indicator declining while the indices pushed higher. That pattern has now resolved, with the indices starting a pullback, breaking below their 10-day exponential moving average, and showing signs of losing momentum.
This downward turn is further confirmed by the VIX, which has climbed back over the critical 20.00 level. As we've noted before, a VIX above this threshold is usually not a good sign and suggests that the low-volatility bullish trend may be facing headwinds. The combination of the indices losing key moving averages and the VIX showing renewed fear points towards a more cautious market environment ahead.
From a trading perspective, this week presented very few successful opportunities. While we attempted a couple of trades without much success, DGXX stood out as a big winner for our swing trading portfolio. However, the most annoying event of the week was our exit from SEZL. While it was not a meaningful position, we made a poor decision by exiting when it broke the 20-day exponential moving average intra-day, without waiting for the daily close to see if it could reclaim the level. It was a bad mistake, as the stock recouped all its losses and then some.
Given the current conditions, we are pretty happy to be positioned mostly in cash.
Looking ahead, we are observing a significant shortage of setups that fit our trading style. The number of quality opportunities for next week is currently very low. For this reason, the free watchlist will not be available this week.
For the most immediate access to our commentaries, real-time trade ideas, and daily watchlists, the best place to be is our chat. If you're looking to stay ahead with daily insights and analysis, consider joining our community!
T2108
This week, the T2108 indicator, now at 53.75, broke the consolidation pattern it held for the last few weeks. In a significant shift, it has fallen below its 10-day exponential moving average (10ema) in lockstep with the broader market indices. The strong correlation between the T2108, the T2118, and the indices confirms that this pullback is real and reflects broad participation across the market, resolving the divergence we had been monitoring.
The 4% Bull-Bear Indicator provided a clear picture of this reversal. The week began with bulls in control, but they progressively lost steam as the sessions advanced. By Friday, the dynamic had completely flipped, with bears taking full control of the tape. This intra-week shift from bullish to bearish dominance underscores the loss of short-term momentum.
The 25% Bull-Bear Indicator is giving us a clear clue about the longer-term picture, reinforcing the theme of weakening bullish conviction. This indicator also shows bulls losing steam, raising questions about the durability of the underlying trend. For now, we must wait to see whether this is simply a healthy pullback or the beginning of a more significant correction.
Latest articles:
🌱 Support Our Work: Buy Us a Coffee or Shop Our Services! 🌱
Your small gesture fuels our big dreams. Click below to make a difference today.
[☕ Buy Us a Coffee]
[🛒 Visit Our Shop]
Each stock on the watchlist will now have a risk grade badge next to its name, reflecting our assessment based on factors such as volatility, share float, technicals, fundamentals, ADR, and more. This badge is designed to help readers gauge the stock's risk profile, providing valuable context for making informed decisions about approaching it.
High risk: ⚠️
Medium Risk: 📊
Low Risk: 🛡️
🆓✨ Watchlist Essentials: Top Free Picks
Our commitment is to quality, not quantity. With the market offering very few high-probability setups, we are pausing the free watchlist this week to avoid forcing trades. Our paid members will receive our analysis on the handful of charts that have passed our rigorous screening.
Put the market on autopilot, experience the Best Platform with TC2000
Explore now →
💎📈 Watchlist Elite: Premium Market Movers
Each selection undergoes rigorous financial analysis, technical evaluation, and strategic assessment, delivering institutional-grade research.
Every week, we showcase one complete premium analysis at no cost, letting you experience firsthand the depth and quality that sets Elite research apart.
IMAB: I-Mab ADR ⚠️
What they do: US-based biotech company focusing on global Immuno-Oncology programs
Why watch?🧬 The divestment provides I-Mab with a healthy balance sheet, boasting over$400 million in cash and the potential to receive up to$80 million more from the deal. Its core assets now consist of three global Immuno-Oncology programs, including uliledlimab, which has shown promising Phase 2 data. This follows a history of high-value partnerships, like the 2020 deal to license lemzopalimab to AbbVie for $2 billion. Lucid Capital recently initiated coverage with a Buy rating and a $5 price target, believing its bispecific antibody, Givastomig, could be a significant value driver as it approaches key clinical data. Technically, after recent high-volume days and a breach of the $2.55 level from 2024, the stock is pulling back on lower-than-average volume. This consolidation allows the 10-day EMA to catch up, potentially setting up a powerful breakout.
Keep reading with a 7-day free trial
Subscribe to Market Moves by GBC to keep reading this post and get 7 days of free access to the full post archives.